News

Filter

Current filters:

None

28 to 37 of 96934 results

Positive Ph III results for Relypsa’s patiromer FOS for hyperkalemia

22-11-2014

US biotech firm Relypsa announced that positive results from the pivotal Phase III program of the company's…

BiotechnologyNephrology and HepatologypatiromerRelypsaRenagelRenvelaResearchSanofiZS PharmaZS-9

AstraZeneca to invest $200 million in expanding US biologics manufacturing center

22-11-2014

Anglo-Swedish pharma major AstraZeneca on Friday unveiled plants to expand its biologics manufacturing…

AstraZenecaBiotechnologyFinancialMedImmuneProductionUSA

EMA unit backs new hep C drugs Exviera and Viekirax from AbbVie

EMA unit backs new hep C drugs Exviera and Viekirax from AbbVie

21-11-2014

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

21-11-2014

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued…

CerdelgaEuropeGenzymePharmaceuticalRegulationSanofi

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

21-11-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive…

DiabetesEuropeNovo NordiskPharmaceuticalRegulationVictoza

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

21-11-2014

The European Medicines Agency has reviewed angina medication Corlentor/Procoralan (ivibradine), manufactured…

Cardio-vascularEuropePharmaceuticalProcoralanRegulationServier

Takeda US president quits

21-11-2014

The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole,…

BoardroomManagementPharmaceuticalTakeda PharmaceuticalUSA

Highlights from the Jefferies 2014 Global Healthcare Conference

Highlights from the Jefferies 2014 Global Healthcare Conference

21-11-2014

Pharma, biotech and health care companies convened in London this week to update investors at the Jefferies…

ALK AbelloClinigen GroupCubistFinancialGW PharmaceuticalsPeter GeorgePharmaceuticalUK

28 to 37 of 96934 results

Parexel

Parexel

Back to top